These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 31538428)

  • 1. Distinct Neural Correlates of Executive Function by Amyloid Positivity and Associations with Clinical Progression in Mild Cognitive Impairment.
    Yoon HJ; Kim SG; Kim SH; Choo ILH; Park SH; Seo EH;
    Yonsei Med J; 2019 Oct; 60(10):935-943. PubMed ID: 31538428
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Amyloid-independent functional neural correlates of episodic memory in amnestic mild cognitive impairment.
    Seo EH; Choo IL;
    Eur J Nucl Med Mol Imaging; 2016 Jun; 43(6):1088-95. PubMed ID: 26613793
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential patterns of regional cerebral hypometabolism according to the level of cerebral amyloid deposition in patients with amnestic mild cognitive impairment.
    Jeon SY; Yi D; Byun MS; Choi HJ; Kim HJ; Lee JH; Baek H; Choe YM; Lee Y; Woo JI; Lee DY
    Neurosci Lett; 2016 Oct; 632():104-8. PubMed ID: 27574728
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Basal forebrain atrophy correlates with amyloid β burden in Alzheimer's disease.
    Kerbler GM; Fripp J; Rowe CC; Villemagne VL; Salvado O; Rose S; Coulson EJ;
    Neuroimage Clin; 2015; 7():105-13. PubMed ID: 25610772
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Amyloid-Independent Amnestic Mild Cognitive Impairment and Serum Apolipoprotein A1 Levels.
    Choi HJ; Seo EH; Yi D; Sohn BK; Choe YM; Byun MS; Lee JM; Woo JI; Lee DY
    Am J Geriatr Psychiatry; 2016 Feb; 24(2):144-53. PubMed ID: 26238231
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Beta-amyloid deposition and cognitive function in patients with major depressive disorder with different subtypes of mild cognitive impairment: (18)F-florbetapir (AV-45/Amyvid) PET study.
    Wu KY; Liu CY; Chen CS; Chen CH; Hsiao IT; Hsieh CJ; Lee CP; Yen TC; Lin KJ
    Eur J Nucl Med Mol Imaging; 2016 Jun; 43(6):1067-76. PubMed ID: 26739329
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Amyloid-PET Levels in the Precuneus and Posterior Cingulate Cortices Are Associated with Executive Function Scores in Preclinical Alzheimer's Disease Prior to Overt Global Amyloid Positivity.
    Ali DG; Bahrani AA; Barber JM; El Khouli RH; Gold BT; Harp JP; Jiang Y; Wilcock DM; Jicha GA
    J Alzheimers Dis; 2022; 88(3):1127-1135. PubMed ID: 35754276
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Topographical APOE ɛ4 Genotype Influence on Cerebral Metabolism in the Continuum of Alzheimer's Disease: Amyloid Burden Adjusted Analysis.
    Seo EH; Kim SH; Park SH; Kang SH; Choo IH;
    J Alzheimers Dis; 2016 Sep; 54(2):559-68. PubMed ID: 27567846
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regional amyloid deposition in amnestic mild cognitive impairment and Alzheimer's disease evaluated by [18F]AV-45 positron emission tomography in Chinese population.
    Huang KL; Lin KJ; Hsiao IT; Kuo HC; Hsu WC; Chuang WL; Kung MP; Wey SP; Hsieh CJ; Wai YY; Yen TC; Huang CC
    PLoS One; 2013; 8(3):e58974. PubMed ID: 23516589
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Episodic memory network characteristics in patients with amnestic mild cognitive impairment accompanied by executive function impairment.
    Wang C; Cheng R; Yang W; Qiu L; Liu H;
    Brain Behav; 2024 Jun; 14(6):e3601. PubMed ID: 38898628
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Discriminative Power of Arterial Spin Labeling Magnetic Resonance Imaging and 18F-Fluorodeoxyglucose Positron Emission Tomography Changes for Amyloid-β-Positive Subjects in the Alzheimer's Disease Continuum.
    Tosun D; Schuff N; Jagust W; Weiner MW;
    Neurodegener Dis; 2016; 16(1-2):87-94. PubMed ID: 26560336
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relationships between flortaucipir PET tau binding and amyloid burden, clinical diagnosis, age and cognition.
    Pontecorvo MJ; Devous MD; Navitsky M; Lu M; Salloway S; Schaerf FW; Jennings D; Arora AK; McGeehan A; Lim NC; Xiong H; Joshi AD; Siderowf A; Mintun MA;
    Brain; 2017 Mar; 140(3):748-763. PubMed ID: 28077397
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Is there a difference in regional read [
    Farrar G; Molinuevo JL; Zanette M
    Eur J Nucl Med Mol Imaging; 2019 Jun; 46(6):1299-1308. PubMed ID: 30863934
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identifying Brain Connectivity Using Network-Based Statistics in Amnestic Mild Cognitive Impairment Stratified by β-Amyloid Positivity.
    Kim JE; Kim SW; Choi M; Seong JK; Lee JH
    Am J Alzheimers Dis Other Demen; 2019 Mar; 34(2):104-111. PubMed ID: 30497273
    [TBL] [Abstract][Full Text] [Related]  

  • 15.
    Chun MY; Lee J; Jeong JH; Roh JH; Oh SJ; Oh M; Oh JS; Kim JS; Moon SH; Woo SY; Kim YJ; Choe YS; Kim HJ; Na DL; Jang H; Seo SW
    Yonsei Med J; 2022 Mar; 63(3):259-264. PubMed ID: 35184428
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Brain metabolism and cerebrospinal fluid biomarkers profile of non-amnestic mild cognitive impairment in comparison to amnestic mild cognitive impairment and normal older subjects.
    Coutinho AM; Porto FH; Duran FL; Prando S; Ono CR; Feitosa EA; Spíndola L; de Oliveira MO; do Vale PH; Gomes HR; Nitrini R; Brucki SM; Buchpiguel CA
    Alzheimers Res Ther; 2015 Sep; 7(1):58. PubMed ID: 26373380
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quantitative Brain Amyloid Measures Predict Time-to-Progression from Amnestic Mild Cognitive Impairment to Alzheimer's Disease.
    Jun S; Kim H; Kim BS; Yoo BG; Lee WG;
    J Alzheimers Dis; 2019; 70(2):477-486. PubMed ID: 31256127
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hybrid PET/MRI with Flutemetamol and FDG in Alzheimer's Disease Clinical Continuum.
    Atay LO; Saka E; Akdemir UO; Yetim E; Balcı E; Arsava EM; Topcuoglu MA
    Curr Alzheimer Res; 2023; 20(7):481-495. PubMed ID: 38050727
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Imaging microglial activation and amyloid burden in amnestic mild cognitive impairment.
    Knezevic D; Verhoeff NPL; Hafizi S; Strafella AP; Graff-Guerrero A; Rajji T; Pollock BG; Houle S; Rusjan PM; Mizrahi R
    J Cereb Blood Flow Metab; 2018 Nov; 38(11):1885-1895. PubMed ID: 29135331
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Independent and Interactive Influences of the APOE Genotype and Beta-Amyloid Burden on Cognitive Function in Mild Cognitive Impairment.
    Seo EH; Kim SH; Park SH; Kang SH; Choo IH;
    J Korean Med Sci; 2016 Feb; 31(2):286-95. PubMed ID: 26839485
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.